NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Month: February 2025
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capri Holdings Limited (“Capri” or the “Company”) (NYSE: CPRI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU) and certain officers. The class action, filed in the United States District Court for the Northern…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) and certain officers. The class action, filed in the United States District Court for the Middle…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Innovative Industrial Properties, Inc. (“IIPR”, “IIP”, or the “Company”) (NYSE: IIPR) and certain officers. The class action, filed in the United States District Court for…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc (“Avis Budget” or the “Company”) (NASDAQ: CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…